Respiratory Flashcards

1
Q

COPD

A

Chronic bronchitis
Emphysema

COPD is a common respiratory condition involving the airways and characterised by airflow limitation
Exacerbations and comorbidities contribute to the overall severity in individual patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Signs and symptoms of emphysema

A

Known as “pink puffer” due to difficulty reathing but are well perfused

Dyspnea
Productive cough
Wheezing
Chest tightness

Pure emphysema patients:
Barrel Chest
Muscle wasting
Pursed lips

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Signs and symptoms of chronic bronchitis

A

“blue bloaters” because they are usually synosed

Dyspnea
Productive cough
Wheezing
Chest tightness

Pure chronic bronchitis:
Peripheral Oedema
Raised JVP due to potential right-sided heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathophysiology of emphysema

A

Pure emphysema affects alveoli. Alveoli are covered in elastic fibers allowing alvoli to expand and recoil back pushing air out as we exhale

However in emphysema what we see is a loss of elastic fibers and decrease in surgace area of the alveoli, this could lead to collapsed alveoli
Can also get air trapping which is where air is still trapped in the alveoli as we exhale because the recoil mechanism isn’t working

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pathophysiology of chronic bronchitis

A

Problems along bronchioles. In chronic bronchitis you have smooth muscle hypertrophy and contraction as well as mucus hypersecretion. Leads to difficulty breathing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Risk Factors for COPD

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Investigations for COPD

A

1.Spirometry: FEV1/FVC ratio >70%
When evaluationg a patient with possible COPD spirometry is performed. Spirometry is performed pre and post bronchodilator administration to determine whether airflow limitation is present, partial or fully restrictive

2.X-Ray:
-Flattened diaphragm
-Hyperexpansion -> Hyperinflation

  1. Pulse oximetry -> check for O2 sat
    Decreased O2 -> Hypoxemia
  2. FBC -> check for amaemia
  3. Arterial blood gas
    Is it respiratory acidosis/alkalosis
    Late Stage COPD usually decreased O2 and increased CO2
  4. ECG
    Check for heart involvement
    Rule out MI, heart Failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Diagnosis of COPD

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Management of COPD

A
  1. Smoking Cessation
  2. Vaccination
  3. Bronchodilators: B2 agonists/anticholinergic. Short/Long acting
  4. Corticosteroids: inhaled glucocorticosteroids used in combination with long acting bronchodilators -> corticosteroids are not used alone
  5. Pulmonary rehab
  6. Oxygen therapy: for chronic COPD who has hypoxemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Classification of COPD

A

Assessment of severity of condition is based on three factors:
1.Severity of symtpoms
2.Spirometry
3.Risk of exacerbations

Using the three features -> COPD classification -> Gold guidelines for COPD management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is asthma

A

Chronic inflammatory disease affecting the lower airway, characterised by hyperresponsiveness and bronchospasm leading to airway narrowing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pathophysiology of asthma

A

Triggers:
Allergic: pollen, pets
Nonallergic: smoking, perfumes

Trigger taken by dendritic cell and presented to T-helper 2 cell. TH2 cells produce IL-4, IL-13 (cause plasma cells to release IgE. IgE activated mast cells to cause degranulation. Granules include histamine leukotriene, prostaglandin- type 1 hypersensitivty reaction -> bronchospasm, increased mucus production, oedema. This narrows airway and produces symptoms) and IL-5 (leads to activation of eosinophils which release more cytokines and leukotriene contibuting to symptoms as well.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Acute exacerbation of asthma vs long term

A

Acute: Reversible

Long term: remodelling. Irreversible
1. Subepithelial fibrosis
2. Smooth muscle hypertrophy
3. Increased mucus production
4. Increased vascuarity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Causes/Risk Factors of asthma

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Signs and symptoms of asthma

A

Recurrent episodes:
1.Dyspnea
2.Wheezing
3.Chest tightness
4.Coughing

Often worse at night or in response to exercise/cold air

Associated:
Anxiety
Obstructive sleep apnea
GORD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Complications of asthma

A

Remodelling: COPD
Increased rates of anxiety and depression

Asthma can be lethal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Diagnosis of asthma

A

Acute Exacerbation severity (mnemonic)
A: Altered consciousness
Arrhythmia
C: Cyanosis. PaCO2
H: Hypotension/Hypoxia
E: Exhaustion
S: Silent chest
T: Threatening PEF (<=33% Of best)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Treatment for asthma

A

No definitve cure. Stepwise approach

Long term: Assess-> Adjust -> Review (Repeat)
1.Short acting B2 agonist (salbutamol). SABA used as a reliever in most steps
2.Low dose inhaled corticosteroids
3.Long acting B2 agonist (salmeterol) + increasing ICS doses
4.Leukotriene receptor antagonists (montelukast)
5.Long acting anti-muscarinic (tiotropium)
6.Targeted Therapy: Anti IgE (omalizumab). Anti IL4/IL5

Acute Exacerbations:
1. O2
2. Nebulisers: Salbutamol, ipratropium
3. Systemic corticosteroids: prednisolone
If unresolved:
4. Mechanical sulfate
5. Mechanical Ventilation

Viral infections are common triggers, antibiotics given if baterial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Lung Infections

A

TB
Pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is tuberculosis

A

Bacterial infection caused by “mycobacterium tuberculosis complex”
Characterised by the presence of chronic granulomatous inflammatory reaction

99% Mycobacterium tuberculosis
Mycoacterium bovis: Oropharyngeal & Intestinal TB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Mycobacterium Tuberculosis

A

Obligate aerobe
Intracellular pathogen
Grow very slowly
Lipid rich cell wall - mycolic acid
Do not stain with gram stain
Mannose capped glycolipids to bind macrophages
Able to survive and multiply inside macrophages by avoiding lysosomal killing
Acid & alcohol fast bacilli - do not decolourise with acid or alcohol when stained with Ziehl Nielson stain
Sensitive to: Heat, UV light, alcohol fermaldehyde, gluteraldehyde
Primarily infects lungs, intestine, bone, liver, kidney, brain, eye

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Risk Factors for TB

A

HIV infection: serious risk factor for TB
Alcoholism
Diabetes Mellitus
Recent surgery
Immunosuppressive therapy - corticosteroids
Workers in healthcare facilites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Types of TB

A

2 types:
1. Primary TB - in non-sensitised hosts
2. Post-Primary (secondary) TB - in sensitised hosts

Spectrum of disease based on the immune response of the host

  1. Active TB - multiplying bacilli
    -Pulmonary TB
    -Extra pulmonary TB
    -Miliary TB - Blood stream spread wih high bacillary load

2.Latent TB -Dormant bacilli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Pathogenesis of Primary Pulmonary TB

A

Primary Pulmonary TB - In non sensitised hosts

Inhalation of M.tuberculosis -> Bacilli get lodged in the “upper part of the lower lobe, or lower part of the upper lobe sub pleurally” -> Bacteria are engulfed by the alveolar macrophages -> Survive inside the macrophage -> Unchecked bacillary proliferation (first 3 weeks) -> Bacgeria spread via lymphatics & blood stream to the other parts of the body -> Asymptomatic/Mild flu like illness

  • Macrophage response -> Inflammation (Ghon’s focus)
  • Bacilli are taken to the lymph nodes via lymphatics -> Inflammation at the lymph nodes
  • Bacilli in lymph nodes -> Macrophage presents processed Mycobacterual antigens to CD4 T cells (> 3 weeks) -> T cells become T helper cells -> T helper cells secrete cytokines acivating macrophages
  • Activated macrophages:
    1: Kill the bacilli by varous mechanisms: ROS, RNS, proteases -> Most bacilli get killed, but some may remain dormant for several years.
    2: Secrete cytokines (TNF) -> Recruit more macrophages/Macrophage activation/Differentiation of macrophages into epithelioid cells -> formuation of granulomas

Possible outcomes of Primary Pulmonary TB
Control of the infection in immunocompetent hosts with healed lesions
Granuloma -> Heals by fibrosis -> Dystrophic calcification -> Ossification

Some bacilli may remain dormant
In immunocompromised patients: Primary pulmonary TB -> Progressive pulmonary TB

Progressive Primary TB
Most often resembles an acute bacterial pneumonia
Pleural effusion
Lung collapse
Cavitation is rare
Lower and middle lobe consolidation
Dissemintation of bacilli via lymphatics & blood stream -> Miliary TB/TB meningitis/TB lymphadenitis/TB spine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Secondary (Post primary) Pulmonary TB - in sensitised hosts
26
Progression of secondary TB
27
Miliary TB
28
Systemic miliary TB
29
Extra pulmonary TB
30
Clinical Presentation of TB
Chronic cough (>2 weeks) - dry/productive Low grade fever - remittent (appears late afternoon & fades out) Anorexia Weight Loss Night Sweats Progressive pulmonary involvement - increasing amounts of sputum Haemoptysis (advanced) - agressive disease (invasion of blood vessels) Pleuritic chest pain
31
Diagnosis of TB
Primarily based on history, signs and symptoms and radiographic findings 1.Sputum direct smear for acid fast bacilli Stained in bright red with Ziehl Nielson stain Need 3 sputum samples - early morning sample is best Most commonly used method Cannot differentiate between species Cannot test antibiotic sensitivity 2.Mycobaterial culture Need only 1 sputum sample Can differentiate between species Takes 4-12 weeks to bet result 3. PCR Rapid detection Can detect antibiotic resistance genes 4. Mantoux test - screening method
32
Treatment for TB
33
Prevention of TB
34
What is pneumonia
Infection/Inflammation of the lungs
35
Signs and symtpoms of pneumonia
36
Risk Factors for pneumonia
37
Pulmonary Defences
38
Causes of pneumonia
Impaired pulmonary defence makes an individual more susceptible to getting pneumonia
39
Examples of impaired pulmonary defences
40
Pathophysiology of pneumonia
Bacteria “translocate” to normally sterile distal airway - bacteria from URT that has either came in quickly or colonised for a while are micro-aspirated into lower lung Resident host cells become overwhelmed Develop an inflammatory response – neutrophils and inflammatory exudate fill alveolar space Resolution phase – when bacteria cleared Inflammatory cells removed by apoptosis Resolution phase leads to complete recovery In pneumonia you see: Fluid filled alveoli Bronchoconstriction Increase in mucus secretion Consolidation: process that fills the alveoli with fluid, pus, blood, cells resulting in lobar diffuse opacities
41
Types of pneumonia based on areas of lung affected
Lobar pneumonia Broncho pneumonia
42
Lobar pneumonia
43
Broncho pneumonia
Bronchopneumonia affects patches throughout both lungs Infection spreads along airway and finally reaches distal areas Tendency for secretion to graduate to longer lobes
44
When to hospitalise patients with pneumonia (community acquired pneumonia)
If greater than 2, needs to be hospitalised
45
Transmission of pneumonia
46
Types of pneumonia based on where infection was acquired and cause of infection
Community Acquired pneumonia Hospital acquired pneumonia Aspiration pneumonia Chronic pneumonia
47
Community Acquired Pneumonia
48
Hospital Acquired Pneumonia
49
Aspiration pneumonia
Lung abscess complication: Extention to pleural cavity Haemorrhage Brain abscess Meningitis Secondary amylodosis
50
Chronic pneumonia
51
Complication of pneumonia
52
Investigations for pneumonia
1. Chest X Ray Patchy "bronchopneumonia" Consolidation "lobar" 2. Sputum testing (Gram Stain) To identify bacteria MCS 3. Urine antigen testing Identify bacteria: strep pneumonia or legionella 4. Blood testing FBC: WBC increase/decrease indicates severity. Neutrophilia indicates bacteria. Haemolytic anaemia suggests mycoplasma EUC testing: Urea high indicates severity LFT: Abnormal if basal pneumonia inflames liver
53
Pneumonia treatment
1. Oxygen: All patients with tachypnoea, hypoxemia, hypotension or acidosis Cardinal signs of Pneumonia: Chest Pain Dyspnoea Exudate (sputum) Fever 2. Intravenous fluids: Severe patient, elerly. Increase in vomitng 3. Pain: NSAIDs, opiods 4. Antibiotics
54
What pneumonia is mot common in HIV patients
Pneumocystis pneumonia is most common in HIV patients
55
What is cystic fibrosis
One of the most common autosomal recessive disease Cystic fibrosis is a disease resulting from abnormality in the cystic fibrosis conducting regulator Clinical Manifestation: Pancreatic dysfunction, Lung disease, and salty sweat
56
Clinical Presentation of cystic fibrosis
The clinical presentation of cystic fibrosis defer in infants and children. Infants Meconium ileus (bowel obstruction due to poo) Rectal prolapse Children - Mainly failure to thrive and recurrent upper respiratory tract infection Chronic cough and wheezing FTT Pancreatic insufficiency (symptoms of malabsorption such as steatorrhea) Alkalosis and hypotonic dehydration Neonatal intestinal obstruction (meconium ileus)/Nasal polyps Clubbing of fingers/Chest radiograph with characteristic changes Rectal prolapse Electrolyte elevation in sweat, salty skin Absence or congenital atresia of vas deferens Sputum with S. aureus or P. aeruginosa (mucoid) Remember Cystic Fibrosis usually presents in childhood as recurrent lung infections that become persistent and chronic
57
Differential diagnosis of cystic fibrosis
Failure to thrive Asthma Coeliac Disease GORD Immunodeficiency disorders
58
Investigations for cystic fibrosis
Infant have a Heel prick - Immunoreactive Trypsinogen (IRT) to detect cystic fibrosis Side note Heel prick is performed to screen for metabolic disease of the newborn inlcuding: galactosemia, cystic fibrosis, phenylketouria, sickle-cell disease and congenital hypothyroidism Sweat test - first line for diagnosis >60mmol/L Genetic screening - Type of CFTR mutation
59
Aetiology of cystic fibrosis
Aetiology A mutation of the CFTR gene on the long arm of chromosome 7 is the cause of cystic fibrosis. The mutation of the CTFR gene results in a mutated CFTR protein which is a transported for Cl- ions. The severity of cystic fibrosis depends on the type of mutation found on the CFTR gene.
60
Pathophysiology of cystic fibrosis
Pathophysiology Cystic Fibrosis is caused by mutated CTFR protein. The CFTR protein is found on the apical surface of many hollow tissues notably the lungs, pancreas, gastrointestinal tract and sweat glands. The CTFR protein is a transporter for Cl-. A mutated CFTR protein can not transport Cl- properly and as a result this causes a disregulated ion distribution. Whereever Cl- exists Na+ will follow because of the electrochemical gradient. When Na+ move water tends to follow. This basic principle is the cause of the signs and symptoms seen in Cystic Fibrosis Remember Cystic Fibrosis is characterized by the triad of chronic obstructive pulmonary disease, pancreatic exocrine deficiency, and abnormally high sweat electrolyte concentrations.
61
Management of Cystic fibrosis
Management of meconium illeus performed after delivery. General High fat, high calorie diet Pancreatic enzyme supplement Vitamin supplementation (ADEK) Salt supplementation Pulmonary care physiotherapy shaking chest jackets Long-term antibiotics (inhaler) Bronchodilator Ongoing management Management of upper respiratory tract infection Oral Antibiotics IV antibiotics Management of non-pulmonary complications Remember patients with CF are at risk of having recurrent URTI which can be caused by S. aureus, H. Influenzae, P. aerugenosa.
62
Complications of cystic fibrosis
63
What is bronchiectasis
Irreversible dilation of the airways due to inflammatory destruction of airway walls resulting from persistently infected mucus P.aureginosa is the most common pathogen Clinical manifestations include: chronic cough copious mucopurelent expectoration Common in patients with cystic fibrosis
64
Risk Factors of bronchiectasis
Cystic fibrosis Host immunodeficiency Previous infections Congenital disorders of the bronchial airways Primary ciliary dyskinesia Alpha-1 antitrypisn deficiency Connective tissue disease Inflammatory bowel disease Aspiration or inhalation
65
Clinical Presentation of bronchiectasis
Remember Massive haemoptysis is >500ml blood loss in 24hrs Examination: Percussion resonant, mixed predominant coarse crackles, often additional polyphonic wheeze. Presence of of high pitch inspiratory squeals and rhonchi
66
Differential diagnosis of bronchiectasis
COPD Asthma Pneumonia Chronic sinusitis
67
Investigations for bronchiectasis
Gold Standard - CT
68
Aetiology of bronchiectasis
69
Pathophysiology of bronchiectasis
Essentially the different causes of bronchiectasis with impaired respiratory defences/ immunodeficiency will trigger an inflammatory process, recurrent infections that will result in the pathological changes seen bronchiectasis. There will be bronchiole dilatation, immune cells infiltration into the tissue (lymphocytes), bronchial ulceration and oedema, smoother muscle hypertrophy and neovascularization. Patients with bronchiectasis gets recurrent infection. Common causes of infections are p. aureginosa, s. pneumoniae, h. influenzae, s. aureus. Infection can trigger exacerbations.
70
Management of bronchiectasis
Remember to treat the underlying cause as well (ie. cystic fibrosis, Rheumatoid arthritis, Inflammatory bowel disease)
71
Complications of bronchiectasis
Massive haemoptysis Respiratory failure Cor pulmonale
72
What is pleural effusion
Accumulation of fluid in the pleural space
73
Pathophysiology of pleural effusion
Mechanisms: Increase pleural fluid formation: 1. Increase in permeability (inflammation) 2. Increase venous pressure 3. Decrease plasma oncotic pressure (hypoproteinaemia) 4. Decrease pleural pressure Pleural fluid protein is not altered by clearence of fluid of lymphatics Decrease pleural fluid clearance 1. Cancer invasion 2. Blockage of lymphatic stoma 3. Mechanical compression (granuloma) 4. Injury from chemotherapy/radiation therapy
74
Clinical examination of pleural effusion
75
Investigations of pleural effusion
Gold Standard: Ultrasound
76
Lights Criteria
Used to differentiate exudative vs transudate pleural effusion
77
Diagnosis of pleural effusion
Ultrasound "gold standard" + thoracocentesis thoracocentesis (pleural fluid analysis: lactate dehydrogenase. protein) Light criteria
78
Causes of transudative vs exudative pleural effusion
Causes of transudative pleural effusion: Increase in peural BNP 1. Congestive Heart Failure 2. Liver Cirrhosis 3. Nephrotic syndrome Causes of exudative pleural effusion: Pleural culture. pleural fluid cell differentiation + glucose 1. Infective 2. Malignancy 3. Pulmnary embolism 4. Gastrointestinal pathology 5. Connective tissue disease
79
Management of pleural effusion
80
Types of pleural effusion
81
What is a pneumothorax
Abnormal collection of air in pleural space -Disrupts negative intrapleural pressure + presence in air and pressure -> Lung size will decrease and collapse
82
Pneumothorax Types & Classification
1. Outside: through chest wall 2. Inside: ruptured lung and pleura Types: 1. Traumatic- cause by trauma Blunt vs Penetrating Iatrogenic (result of invasive procedure): result of positive pressure mechanical ventilation 2. Non-traumatic - spontaneous Primary Spontaneous Pneumothorax (PSP): Normal lung, no known cause Secondary Spontaneous Pneumothorax (SSP): Lung with underlying disease (COPD, Asthma, TB, fibrosis, Cancer, pneumonia) Classification: Simple (No mediastinal shift) vs Tension (mediastinal shift) Open (Open wound chest wall. Air in & out. "Sucking Chest wall") vs Closed (Chest Wall intact)
83
Signs and symptoms of pneumothorax
84
Investigations of pneumothorax
85
Treatment for pneumothorax
86
What is idiopathic pulmonary fibrosis?
Chronic progressive fibrotic interstitial lung disease Primarily occurs in older adults
87
Signs and symptoms of idiopathic pulmonary fibrosis
88
Differential diagnosis for idiopathic pulmonary fibrosis
Heart Failure COPD
89
Risk Factors for Idiopathic Pulmonary Fibrosis
90
Pathphysiology of idiopathic pulmonary fibrosis
Patchy fibrosis of interstitium, minimal or absent inflammation, acute fibroblastic proliferation and collagen deposition.
91
Investigations for idiopathich pulmonary fibrosis
Pulmonary Function Test: Decreased FVC and TLC Diffusing capacity of carbon monoxide: Decreased Chest X-ray: Bilateral reticular infiltrates Hazy opacities Decreased Inspiratory volume High resolution CT chest: Gold Standard Bilateral reticulation Honeycombing: Changes are lower lobe predominant Traction bronchiectasis
92
Differential diagnosis for idiopathic pulmonary fibrosis
93
Treatment for idiopathic pulmonary fibrosis
94
Complications and prognosis for idiopathic pulmonary fibrosis
95
What is sarcoidosis
Multisystem inflammatory disease of unknown aetiology Predominantly affects: lungs, intrathoracic lymph nodes, non-caseating granulomas Characterised by an exaggerated immune response against an unrecognised antigen
96
Causes of sarcoidosis
97
Symptoms of sarcoidosis
98
Pathophysiology of sarcoidosis
Non-caseating granulomata form at various sites in the body, particularly the thoracic cavity, skin and eyes. Bilateral hilar lymphadenopathy and/or pulmonary infiltrations. Contain: Langhans giant cells and non-caseating granulomas
99
Diagnosis of sarcoidosis
Radiological stage by chest radiography at presentation inversely correlates with likelihood of spontaneous resolution. Stage 0: normal Stage I: bilateral hilar lymphadenopathy Stage II: bilateral hilar lymphadenopathy plus pulmonary infiltrates Stage III: pulmonary infiltrates without hilar lymphadenopathy Stage IV: extensive fibrosis with distortion. Typically shows bilateral hilar adenopathy.
100
Treatment of sarcoidosis
101
What is respiratory failure
Acute Respiratory failure causes hypoxia and/or impaired ventilation with hypercapnia, leading to severe hypoxemia and rapid deterioration. Two main types of respiratory failure
102
Types of respiratory failure
Type 1:Hypoxaemia (PaO2<60mmHg) without hypercapnia. Caused by conditions affecting oxygenation: right-to-left shunts or V/Q mismatch Acute Respiratory Failure Type II: Chronic Respiratory Failure Type I respiratory failure (non-hypercapniec respiratory failure) Primarily from failure of oxygenation (PaO2 <60mmHg) Normal or low CO2 pH 7.5 Usually responds to Oxygen therapy Type II respiratory failure (hypercapniec respiratory failure): Hypoxaemia with hypercapnia (PaCO2>50mmHg). Increased CO2 (PaCO2 >50mmHg) Normal or low O2 pH <7.3 Failure of ventilation as well as oxygenation Requires ventilator support as well as supplemtntal oxygen
103
Signs and symptoms of respiratory failure
Clinical Presentation Increased work of breathing Increased RR Use of accessory muscles Tracheal tug Abdominal recession Increased HR Sweating or clammy skin Anxiety or agitation Exhaution and confusion *Other signs and symptoms depending on cause Signs of Hypoxia Cyanosis Low O2 Arrthymia (from hypoxia) Anxiety, agitation Acidosis (tissue hypoxia) Hypoventilation Vasodilation Headache, fatigue Asterixis Acidosis Obstruction Inability to speak Accumulation of secretion Remember Use pulse oximetry, ECG, ABG and Chest X-ray in the initial assessment
104
Causes of respiratory failure
Type I Type II Pneumonia COPD ARDS Life-threatening asthma Interstitial lung Disease Drug Intoxication (opioids) Acute Pulmonary Oedema CVA/trauma Asthma Primary muscles disorders COPD Myasthenia gravis Pneumothorax Poliomyelititis Pulmonary Embolism Kyphoscoliosis Obesity Polyneuropathies Pulmonary hypertension Obesity
105
Pathophysiology of respiratory failure 1
V/Q mismatch Pneumonia ARDS Interstitial Lung disease PE Pneumothorax Right-to-left shunt Physiological: Pneumonia, acute pulmonary oedema, atelectasis Anatomical: intra-cardiac shunts (VSD, ASD), pulmonary AVM Low inspired O2 partial pressure (FiO2) High altitude Diffusion impairment Interstitial lung disease - Restrictive Acute pulmonary oedema ARDS Hypoventilation Obesity
106
Management of respiratory failure 1
Oxygenation (non-invasive) Nasal prongs Simple Mask Venturi mask Treat underlying cause Ventalin - if asthma or COPD to reduce bronchoconstriction Antibiotics – if infection Diuretics – if fluid overload Monitor clinically and with ABG Non-invasive mechanical ventilation CPAP/PEEP Maintain recruitment of collapsed lung Increased functional residual capacity Minimise intrapulmonary shunt BiPAP Invasive mechanical ventilation - if not improving Endotracheal Intubation Tracheostomy Tube
107
Pathophysiology of respiratory failure type 2
Hypercapnia when alveolar ventilation insufficient to excrete volume of CO2 produced by tissue metabolism due to: Decreased minute ventilation COPD Asthma Heart failure Neurological causes Kyphoscoliosis Obesity Increase in dead space ventilation Increased CO2 production Fever, sepsis, seizure, acidosis, carbohydrate load
108
Treatment for respiratory failure type 2
Remember aims of treatment here is to achieving safe oxygen concentration without increasing CO2 and acidosis, while identifying precipitating condition Oxygenation (non-invasive) Nasal prongs Simple Mask Venturi mask Treat underlying cause Ventalin - if asthma or COPD to reduce bronchospasm Antibiotics – if infection Diuretics – if fluid overload Monitor clinically and with ABG Non-invasive mechanical ventilation BiPAP Invasive mechanical ventilation - if not improving Intubation Think Becareful using oxygen in COPD. Severe COPD hypoventilate and retain CO2. Giving uncontrolled O2 may increase CO2.
109
What is lung cancer
Leading cause of cancer related deaths Cigarettes are the major cause of lung cancer
110
Risk Factors for lung cancer
111
Signs and symptoms of lung cancer
112
Differential diagnosis for lung cancer
113
Investigations for lung cancer
General Chest X-Ray - opacity Spirometry - if thinking of obstructive or restrictive lung disease CT Investigation Chest x-ray findings can vary in patients with lung cancer and can include pulmonary opacity, hilar enlargement, pleural effusion and collapsed lung. Investigations for staging CT CT- Biopsy PET scan Pleural fluid aspiration Lung biopsy with bronchoscopy Endobronchial ultrasound Sputum MCS
114
Lung Carcinoma classification
Lung cancer can be broadly divided into either small cell lung carcinoma or non-small cell carcinoma. Non small cell lung carcinoma making up the majority 80% Small cell lung carcinoma (SCLC - 20%) Non-small cell lung carcinoma ( NSCLC - 80%) Adenocarcinoma Squamous cell carcinoma Large cell
115
Management and Staging of lung cancer
Once a patient presents with symptoms or radiographic findings suggestive of lung cancer, the next steps are as follows: 1.Tissue diagnosis to establish malignant diagnosis and histologic type 2.Staging to determine resectability or curative potential 3.Cancer treatment: surgery, radiotherapy, or chemotherapy
116
Complications on lung cancer
NSCLC Post-obstructive pneumonia/hypoxia Superior vena vaca syndrome Paraneoplastic syndromes SCLC Post-obstructive pneumonia/hypoxia Superior vena vaca syndrome Paraneoplastic syndromes Chemothreapy induced hematological toxicity Radiation induced esophageal/lung injury
117
What is mesothelioma
Cancer arising from mesothelium
118
Types of mesothelioma
Pleural mesothelioma Peritoneal mesothelioma Pericardial mesothelioma
119
Cause of mesothelioma
exposure to asbestos
120
Signs and symptoms of mesothelioma
Shortness of breath, dull diffuse chest pain (occasionally pleuritic), weight loss, lethargy. Pleural effusion. History of asbestos exposure, sometimes. Potentially a palpable chest wall mass.
121
Pathophysiology of mesothelioma
Arises from mesothelial cells (80% pleura, rest are peritoneum and pericardium). Deposition of the asbestos fibres in parenchyma -> penetration of the visceral pleura -> transport of the fiber to the pleural surface -> Development of a malignant plaque (asbestos can apparently facilitate foreign DNA entering the cell -> messing with oncogenes etc)
122
Investigations for mesothelioma
CXR: Pleural effusion. Potentially rib destruction. Pleural aspiration: Straw coloured or blood stained. Pleural biopsy: Gold standard
123
Treatment for mesothelioma
Surgical: Ressection (pleurectomy and decortication may relieve pain and effusions) Chemo: Improves survival of patients with unressectable mesothelioma. Radio: Mostly for pain control if at all
124
Causes of dyspnoea
COMMON CAUSES OF CHRONIC DYSPNOEA Respiratory Disease Cardiovascular Disease COPD Myocardial Dysfunction (Heart Failure) Asthma Obesity/de-conditioning Interstitial lung disease
125
Recognise the MRC dyspnoea scale
126
Classification of interstitial lung disease
127
interstitial lung disease: upper lobar predominance "BREASTS"
128
interstitial lung disease: lower lobar predominance "AIDS"
129
Clinical Presentation of Interstitial lung disease
130
Diagnosis of Interstital lung disease
High Res CT - gold standard
131
What is hypersensitivty pneumonitis
Inappropriate immune response to an antigen causing inflammation of the lung extrinsic allergic alveolitis Upper Lobe predominance
132
Types of hypersensitivity pneumonitis
133
Clinical Manifestation of hypersensitivity pneumonitis
134
Treatment of hypersensitivity pneumonitis
135
Differential diagnosis of hypersensitivity pneumonitis
136
Diagnosis of hypersensitivity pneumonitis
137
Pathophysiology of hypersensitivity pneumonitis
138
What is pulmonary hypertension
Increase in blood pressure in the pulmonary circulation Mean arterial pressure >25mmHg
139
Causes of pulmonary hypertension
140
Diagnosis of pulmonary hypertension
141
Treatment for pulmonary hypertension
142
Complications of pulmonary hypertension
Right sided heart failure
143
Causes of croup
Parainfluenza 1 and 2 Respiratory syncytial virus (Common cause of bronchiolitis) Remember Croup symptoms usually start with flu like symptoms. Croup is caused by viruses, with para-influenza virus (types 1 to 3) as the most common
144
Signs and symptoms for croup
Classic Tetrad: barking cough, stridor, hoarse voice, and respiratory distress Agitation Inspiratory stridor Barking Cough Hoarse voice Male Young age Tracheal Tug Lethargy Abrupt onset of symptoms Symptoms worse at night
145
Differential diagnosis for croup
Differentials for stridor Croup (common) Bacterial tracheitis (uncommon) Foreign body Epiglottitis (rare)
146
Investigations for croup
Croup is a clinical diagnosis based on early respiratory infections followed by a barking cough Chest X-ray Neck X-ray - steeple sign
147
Pathophysiology for croup
148
Classification of croup
Mild Airway Obstruction Barking cough without inspiratory stridor Moderate Airway Obstruction Stridor at rest Tracheal tug Chest wall recession Severe Airway Obstruction Persisting stridor Tracheal tug Chest wall recession Aaethetic/restless Soft stridor, irritability, tachycardia, pallor indicates imminent airway obstruction
149
Management of croup
A single dose of dexamethasone is recommended in all patients with croup, including those with mild disease. Nebulized epinephrine is an accepted treatment in patients with moderate to severe croup. Mild Airway Obstruction No need for specific treatment Moderate Airway Obstruction Corticosteroids Oral Prednisalone (1mg/kg) Dexamethasone (0.3mg/kg) +/- Nebulised Adrenaline - Budesonide (2mg) Severe Airway Obstruction Oxygen Corticosteroids Oral Prednisalone (1mg/kg) Dexamethasone (0.3mg/kg) +/- Nebulised Adrenaline - Budesonide (2mg) Monitor Remember Antibiotics have no role in uncomplicated croup as it has a viral aetiology